| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 36 | 2025 | 172 | 5.860 |
Why?
|
| Lupus Nephritis | 6 | 2025 | 37 | 2.010 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2026 | 105 | 1.940 |
Why?
|
| Autoantibodies | 14 | 2025 | 184 | 1.810 |
Why?
|
| Antibodies, Antinuclear | 7 | 2023 | 39 | 1.750 |
Why?
|
| Glomerulonephritis | 4 | 2017 | 32 | 1.700 |
Why?
|
| Apoptosis | 15 | 2014 | 1109 | 1.530 |
Why?
|
| Autoimmunity | 7 | 2025 | 246 | 1.390 |
Why?
|
| Estradiol | 4 | 2018 | 262 | 0.970 |
Why?
|
| Antigens, CD19 | 1 | 2025 | 25 | 0.940 |
Why?
|
| Rheumatic Diseases | 1 | 2026 | 42 | 0.930 |
Why?
|
| Autoantigens | 5 | 2020 | 138 | 0.920 |
Why?
|
| Poly(ADP-ribose) Polymerases | 5 | 2015 | 32 | 0.910 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2024 | 5 | 0.830 |
Why?
|
| Necrosis | 3 | 2014 | 146 | 0.790 |
Why?
|
| Neutrophils | 1 | 2025 | 384 | 0.740 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 299 | 0.700 |
Why?
|
| Dendritic Cells | 7 | 2019 | 534 | 0.680 |
Why?
|
| Kidney | 6 | 2024 | 456 | 0.670 |
Why?
|
| Bacteriuria | 1 | 2020 | 16 | 0.660 |
Why?
|
| Interleukin-1beta | 2 | 2022 | 273 | 0.660 |
Why?
|
| Pulmonologists | 1 | 2020 | 5 | 0.650 |
Why?
|
| Rheumatologists | 1 | 2020 | 7 | 0.650 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 208 | 0.640 |
Why?
|
| Immunity, Innate | 3 | 2025 | 818 | 0.640 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 222 | 0.640 |
Why?
|
| Signal Transduction | 5 | 2021 | 3152 | 0.640 |
Why?
|
| fas Receptor | 6 | 2011 | 56 | 0.610 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 250 | 0.590 |
Why?
|
| Energy Metabolism | 2 | 2019 | 395 | 0.560 |
Why?
|
| Escherichia coli | 2 | 2020 | 728 | 0.540 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 50 | 0.540 |
Why?
|
| Humans | 53 | 2026 | 65554 | 0.510 |
Why?
|
| Pandemics | 3 | 2021 | 676 | 0.510 |
Why?
|
| Autoimmune Diseases | 6 | 2024 | 242 | 0.500 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2016 | 15 | 0.490 |
Why?
|
| HMGB1 Protein | 1 | 2016 | 26 | 0.480 |
Why?
|
| Mice | 28 | 2025 | 11209 | 0.480 |
Why?
|
| Mesangial Cells | 1 | 2015 | 2 | 0.460 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 15 | 0.460 |
Why?
|
| Cytokines | 6 | 2024 | 956 | 0.450 |
Why?
|
| Phagocytosis | 4 | 2005 | 266 | 0.450 |
Why?
|
| Membrane Glycoproteins | 5 | 2020 | 668 | 0.440 |
Why?
|
| Animals | 32 | 2025 | 21533 | 0.440 |
Why?
|
| B-Lymphocytes | 8 | 2025 | 569 | 0.440 |
Why?
|
| Estrogens | 1 | 2015 | 117 | 0.430 |
Why?
|
| Germinal Center | 3 | 2025 | 39 | 0.420 |
Why?
|
| Deoxyribonucleases | 2 | 2011 | 32 | 0.420 |
Why?
|
| T-Lymphocytes | 4 | 2026 | 1012 | 0.400 |
Why?
|
| DNA Fragmentation | 3 | 2007 | 34 | 0.380 |
Why?
|
| Female | 35 | 2025 | 34131 | 0.370 |
Why?
|
| Ultraviolet Rays | 3 | 2003 | 148 | 0.360 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 14 | 0.340 |
Why?
|
| Oxidative Stress | 2 | 2025 | 323 | 0.330 |
Why?
|
| Inflammasomes | 2 | 2025 | 346 | 0.320 |
Why?
|
| Lymphocyte Activation | 5 | 2020 | 757 | 0.320 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2294 | 0.310 |
Why?
|
| Interferon Type I | 4 | 2020 | 196 | 0.310 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1587 | 0.290 |
Why?
|
| Sex Factors | 4 | 2018 | 997 | 0.280 |
Why?
|
| Male | 21 | 2023 | 31083 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 13 | 2025 | 3468 | 0.260 |
Why?
|
| Mice, Knockout | 6 | 2025 | 2149 | 0.250 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 801 | 0.250 |
Why?
|
| Interferons | 2 | 2021 | 73 | 0.250 |
Why?
|
| Inflammation | 3 | 2021 | 1186 | 0.240 |
Why?
|
| Middle Aged | 15 | 2023 | 18277 | 0.240 |
Why?
|
| Chromatin | 3 | 2007 | 643 | 0.240 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2025 | 261 | 0.240 |
Why?
|
| Symptom Flare Up | 1 | 2025 | 16 | 0.240 |
Why?
|
| Methylprednisolone | 1 | 2025 | 38 | 0.240 |
Why?
|
| Opsonin Proteins | 1 | 2005 | 30 | 0.230 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2025 | 33 | 0.230 |
Why?
|
| Cells, Cultured | 7 | 2019 | 2214 | 0.230 |
Why?
|
| Plasma Cells | 1 | 2025 | 53 | 0.220 |
Why?
|
| Extracellular Traps | 1 | 2025 | 45 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 219 | 0.220 |
Why?
|
| Young Adult | 3 | 2025 | 4831 | 0.210 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 2 | 2015 | 18 | 0.210 |
Why?
|
| Phagocytes | 1 | 2004 | 52 | 0.210 |
Why?
|
| Survival Rate | 2 | 2021 | 861 | 0.210 |
Why?
|
| Disease Progression | 4 | 2021 | 1218 | 0.210 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 242 | 0.210 |
Why?
|
| Interferon-alpha | 1 | 2024 | 102 | 0.210 |
Why?
|
| DNA, Z-Form | 1 | 2023 | 1 | 0.210 |
Why?
|
| DNA, B-Form | 1 | 2023 | 3 | 0.210 |
Why?
|
| ErbB Receptors | 1 | 2024 | 127 | 0.200 |
Why?
|
| Immunosuppressive Agents | 1 | 2025 | 384 | 0.200 |
Why?
|
| Antigen Presentation | 1 | 2005 | 242 | 0.200 |
Why?
|
| Models, Genetic | 1 | 2004 | 269 | 0.200 |
Why?
|
| Gene Expression | 2 | 2017 | 867 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 197 | 0.190 |
Why?
|
| Double-Blind Method | 2 | 2021 | 749 | 0.190 |
Why?
|
| Treatment Outcome | 2 | 2025 | 5822 | 0.190 |
Why?
|
| Culture Media, Serum-Free | 1 | 2002 | 10 | 0.190 |
Why?
|
| Ceramides | 1 | 2002 | 24 | 0.180 |
Why?
|
| Ferritins | 1 | 2021 | 31 | 0.170 |
Why?
|
| Betacoronavirus | 2 | 2020 | 182 | 0.170 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 1575 | 0.170 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2021 | 49 | 0.170 |
Why?
|
| Endogenous Retroviruses | 1 | 2021 | 12 | 0.170 |
Why?
|
| Adult | 14 | 2023 | 17417 | 0.170 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 793 | 0.170 |
Why?
|
| Etoposide | 1 | 2020 | 33 | 0.170 |
Why?
|
| Aged | 6 | 2021 | 14958 | 0.170 |
Why?
|
| Lymphocytes | 3 | 2011 | 204 | 0.160 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 375 | 0.160 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 167 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 426 | 0.160 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 36 | 0.160 |
Why?
|
| Fas Ligand Protein | 4 | 2002 | 42 | 0.160 |
Why?
|
| Vitamin K | 1 | 1999 | 15 | 0.150 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 114 | 0.150 |
Why?
|
| Interleukin-27 | 1 | 2019 | 6 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 114 | 0.150 |
Why?
|
| Pyruvates | 1 | 2019 | 3 | 0.150 |
Why?
|
| Universities | 1 | 2020 | 170 | 0.150 |
Why?
|
| Immunomodulation | 1 | 2019 | 32 | 0.150 |
Why?
|
| Disease Susceptibility | 2 | 2017 | 167 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 175 | 0.140 |
Why?
|
| Feces | 1 | 2019 | 117 | 0.140 |
Why?
|
| Interleukin-10 | 1 | 2019 | 164 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 1172 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2019 | 154 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 194 | 0.140 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 183 | 0.140 |
Why?
|
| Ligands | 4 | 2019 | 420 | 0.140 |
Why?
|
| Antigen-Antibody Complex | 1 | 2017 | 52 | 0.140 |
Why?
|
| Interferon-gamma | 1 | 2020 | 582 | 0.130 |
Why?
|
| Jurkat Cells | 4 | 2005 | 110 | 0.130 |
Why?
|
| Forecasting | 1 | 2018 | 232 | 0.130 |
Why?
|
| Biomarkers | 3 | 2020 | 1473 | 0.130 |
Why?
|
| Terpenes | 2 | 2007 | 30 | 0.130 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 115 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 164 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2018 | 274 | 0.120 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 37 | 0.120 |
Why?
|
| Urinalysis | 1 | 2016 | 37 | 0.120 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 228 | 0.120 |
Why?
|
| Creatinine | 1 | 2016 | 134 | 0.120 |
Why?
|
| Cell Differentiation | 2 | 2025 | 1394 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2015 | 62 | 0.120 |
Why?
|
| Computational Biology | 1 | 2017 | 364 | 0.120 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2021 | 72 | 0.110 |
Why?
|
| Lipopolysaccharides | 3 | 2019 | 630 | 0.110 |
Why?
|
| Avian Proteins | 1 | 2015 | 7 | 0.110 |
Why?
|
| Salmonella Infections | 1 | 2015 | 42 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 46 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 468 | 0.110 |
Why?
|
| Th1 Cells | 1 | 2015 | 173 | 0.110 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 49 | 0.110 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 88 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 157 | 0.110 |
Why?
|
| Amyloid | 1 | 2015 | 71 | 0.110 |
Why?
|
| Phospholipids | 2 | 2021 | 82 | 0.110 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 86 | 0.110 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 90 | 0.110 |
Why?
|
| Calcium Channels | 1 | 2015 | 104 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 259 | 0.110 |
Why?
|
| Mice, Inbred NZB | 3 | 2024 | 21 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2020 | 2632 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 108 | 0.100 |
Why?
|
| Models, Immunological | 1 | 2014 | 86 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 379 | 0.100 |
Why?
|
| Hospitalization | 1 | 2021 | 1393 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 551 | 0.100 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 271 | 0.100 |
Why?
|
| Spleen | 3 | 2019 | 479 | 0.100 |
Why?
|
| Calcium Signaling | 1 | 2015 | 165 | 0.100 |
Why?
|
| Risk Factors | 2 | 2020 | 5441 | 0.100 |
Why?
|
| Interleukin-1 | 3 | 2021 | 156 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 180 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2019 | 639 | 0.100 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2013 | 83 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2003 | 143 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2003 | 392 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2005 | 1613 | 0.090 |
Why?
|
| Splenomegaly | 1 | 2011 | 22 | 0.090 |
Why?
|
| Hydrolysis | 2 | 2003 | 149 | 0.090 |
Why?
|
| Immunoglobulin G | 5 | 2007 | 461 | 0.090 |
Why?
|
| Myeloid Cells | 1 | 2012 | 97 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2002 | 61 | 0.090 |
Why?
|
| Cellular Senescence | 1 | 2012 | 121 | 0.090 |
Why?
|
| Autoimmune Lymphoproliferative Syndrome | 1 | 2010 | 1 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2002 | 134 | 0.080 |
Why?
|
| Immune Tolerance | 1 | 2011 | 181 | 0.080 |
Why?
|
| Phenotype | 2 | 2024 | 1241 | 0.080 |
Why?
|
| T-Box Domain Proteins | 1 | 2010 | 39 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 1638 | 0.080 |
Why?
|
| Cell Death | 2 | 2019 | 290 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2002 | 347 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 466 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 788 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2010 | 245 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2011 | 421 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 742 | 0.070 |
Why?
|
| Gamma Rays | 1 | 2007 | 32 | 0.070 |
Why?
|
| Zinc | 2 | 1998 | 95 | 0.070 |
Why?
|
| Cell Survival | 2 | 2019 | 600 | 0.060 |
Why?
|
| Lupus Vulgaris | 1 | 2006 | 3 | 0.060 |
Why?
|
| Biofilms | 2 | 2019 | 83 | 0.060 |
Why?
|
| Mice, Mutant Strains | 3 | 2020 | 302 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 681 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2006 | 112 | 0.060 |
Why?
|
| Binding Sites, Antibody | 1 | 2005 | 21 | 0.060 |
Why?
|
| Receptors, IgG | 1 | 2005 | 41 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 116 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 1995 | 33 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 711 | 0.050 |
Why?
|
| Quinazolines | 1 | 2024 | 22 | 0.050 |
Why?
|
| CD40 Antigens | 2 | 2019 | 59 | 0.050 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2003 | 50 | 0.050 |
Why?
|
| Antigens, Nuclear | 1 | 2003 | 20 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2003 | 52 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 378 | 0.050 |
Why?
|
| Data Accuracy | 1 | 2024 | 31 | 0.050 |
Why?
|
| Fibrosis | 1 | 2024 | 173 | 0.050 |
Why?
|
| Blood Platelets | 2 | 1995 | 109 | 0.050 |
Why?
|
| Rheumatoid Factor | 3 | 2002 | 13 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 501 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 107 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2003 | 71 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2023 | 137 | 0.050 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 136 | 0.050 |
Why?
|
| Patients | 1 | 2024 | 114 | 0.050 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 30 | 0.050 |
Why?
|
| Anisomycin | 1 | 2002 | 6 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 23 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 460 | 0.050 |
Why?
|
| Urban Health | 1 | 1982 | 40 | 0.050 |
Why?
|
| Histones | 1 | 2005 | 499 | 0.040 |
Why?
|
| Health | 1 | 1982 | 31 | 0.040 |
Why?
|
| DNA | 2 | 2023 | 855 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2021 | 118 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2021 | 38 | 0.040 |
Why?
|
| Macrophages, Peritoneal | 1 | 2001 | 76 | 0.040 |
Why?
|
| Philadelphia | 1 | 2020 | 24 | 0.040 |
Why?
|
| Bias | 1 | 2021 | 116 | 0.040 |
Why?
|
| Thrombophilia | 1 | 2020 | 14 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2019 | 1156 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2020 | 47 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2020 | 75 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2021 | 325 | 0.040 |
Why?
|
| Early Medical Intervention | 1 | 2020 | 21 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2001 | 237 | 0.040 |
Why?
|
| Transplantation Chimera | 1 | 2020 | 41 | 0.040 |
Why?
|
| Macrophages | 1 | 2006 | 1060 | 0.040 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 1999 | 10 | 0.040 |
Why?
|
| Serine | 1 | 2020 | 92 | 0.040 |
Why?
|
| Molecular Mimicry | 1 | 2019 | 31 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1999 | 112 | 0.040 |
Why?
|
| Glutathione | 1 | 1999 | 58 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 155 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 142 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2019 | 53 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 198 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2019 | 56 | 0.040 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2020 | 104 | 0.040 |
Why?
|
| Genome, Human | 1 | 2021 | 242 | 0.040 |
Why?
|
| Imidazoles | 1 | 2019 | 86 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 78 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1998 | 22 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 106 | 0.040 |
Why?
|
| Immune Sera | 1 | 1998 | 35 | 0.040 |
Why?
|
| Chronic Disease | 1 | 1982 | 757 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2018 | 37 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2015 | 674 | 0.040 |
Why?
|
| Anxiety | 1 | 2021 | 438 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2019 | 245 | 0.030 |
Why?
|
| Solubility | 1 | 1998 | 192 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2019 | 233 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2019 | 181 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1998 | 70 | 0.030 |
Why?
|
| Volition | 1 | 1997 | 10 | 0.030 |
Why?
|
| Genomics | 1 | 2021 | 394 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 295 | 0.030 |
Why?
|
| Saccades | 1 | 1997 | 15 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 219 | 0.030 |
Why?
|
| Oculomotor Muscles | 1 | 1997 | 11 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 977 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 238 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 45 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 801 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2019 | 435 | 0.030 |
Why?
|
| Copper | 1 | 1998 | 56 | 0.030 |
Why?
|
| Microbiota | 1 | 2019 | 165 | 0.030 |
Why?
|
| Biliopancreatic Diversion | 1 | 1996 | 2 | 0.030 |
Why?
|
| Mutation | 2 | 2002 | 2688 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1410 | 0.030 |
Why?
|
| Arthritis | 1 | 1996 | 53 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2015 | 35 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 167 | 0.030 |
Why?
|
| Allografts | 1 | 2015 | 48 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1793 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 94 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1995 | 48 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 41 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 1995 | 77 | 0.030 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1995 | 3 | 0.030 |
Why?
|
| ORAI1 Protein | 1 | 2015 | 4 | 0.030 |
Why?
|
| Stromal Interaction Molecule 1 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Polymerization | 1 | 2015 | 36 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 1996 | 95 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 211 | 0.030 |
Why?
|
| Chickens | 1 | 2015 | 94 | 0.030 |
Why?
|
| Bone Density | 1 | 1995 | 143 | 0.030 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1994 | 12 | 0.030 |
Why?
|
| Posture | 1 | 1995 | 128 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 619 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1308 | 0.030 |
Why?
|
| Transcriptome | 1 | 2018 | 410 | 0.030 |
Why?
|
| Cell Line | 2 | 2015 | 2068 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1998 | 344 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 877 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 179 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 1441 | 0.030 |
Why?
|
| Aging | 2 | 2011 | 766 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 440 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2510 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 358 | 0.020 |
Why?
|
| c-Mer Tyrosine Kinase | 2 | 2002 | 3 | 0.020 |
Why?
|
| CD4-CD8 Ratio | 1 | 2011 | 16 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 2011 | 37 | 0.020 |
Why?
|
| Immunoglobulin M | 3 | 1998 | 113 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2700 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 153 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2011 | 228 | 0.020 |
Why?
|
| Time Factors | 2 | 2012 | 3788 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1996 | 1326 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2010 | 290 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 6884 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 458 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 923 | 0.020 |
Why?
|
| B7-2 Antigen | 1 | 2006 | 32 | 0.020 |
Why?
|
| Adolescent | 4 | 1996 | 6377 | 0.020 |
Why?
|
| B7-1 Antigen | 1 | 2006 | 74 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 2005 | 12 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 191 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2005 | 47 | 0.010 |
Why?
|
| Liposomes | 1 | 2006 | 116 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 892 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 880 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 2002 | 2 | 0.010 |
Why?
|
| Cardiolipins | 1 | 2002 | 6 | 0.010 |
Why?
|
| Rhodamines | 1 | 2002 | 20 | 0.010 |
Why?
|
| Proteinuria | 1 | 2002 | 43 | 0.010 |
Why?
|
| Mitochondria | 1 | 2005 | 404 | 0.010 |
Why?
|
| Brazil | 1 | 1982 | 105 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 2001 | 24 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2001 | 58 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 2001 | 34 | 0.010 |
Why?
|
| Receptors, Fc | 1 | 2001 | 25 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 118 | 0.010 |
Why?
|
| Microspheres | 1 | 2001 | 57 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2001 | 110 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2001 | 139 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2001 | 216 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 204 | 0.010 |
Why?
|
| Health Surveys | 1 | 1982 | 318 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2001 | 211 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1982 | 800 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 906 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1982 | 1018 | 0.010 |
Why?
|
| Ceruloplasmin | 1 | 1998 | 3 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 1998 | 7 | 0.010 |
Why?
|
| src Homology Domains | 1 | 1998 | 21 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1998 | 55 | 0.010 |
Why?
|
| Acute-Phase Proteins | 1 | 1998 | 36 | 0.010 |
Why?
|
| Complement C3 | 1 | 1998 | 59 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 167 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1998 | 79 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1998 | 295 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 369 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 388 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 524 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 424 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 205 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 1998 | 146 | 0.010 |
Why?
|
| Platelet Count | 1 | 1995 | 26 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 1346 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1998 | 623 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 1618 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 2016 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1982 | 2782 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 495 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1995 | 1114 | 0.010 |
Why?
|
| Child | 1 | 1994 | 4681 | 0.000 |
Why?
|